Rama Krishna Sangem
Apollo Proton Cancer Centre (APCC), the first and largest Proton Therapy Centre in South Asia and the Middle East, is poised to revolutionize global healthcare. In collaboration with Belgium-based IBA, a global leader in proton therapy, APCC, in its series of training programs on PBT, recently completed imparting training to its first batch of eminent doctors from Indonesia and Vietnam.
Through this initiative, India becomes the first country in Southeast Asia to host a specialized proton beam therapy training program for international oncologists., said a press release on March 21, Thursday.
Being the first Indian cancer centre to launch the training program in PBT, it marks a new chapter in collaborative cancer treatment and solidifies its position as a front-runner in knowledge sharing and advancing global cancer care. Similar training programs are in the pipeline for oncologists from Kazakhstan, Malaysia, Slovenia and Philippines.
Proton Beam Therapy has emerged as a highly precise and effective radiation treatment for various cancers, offering targeted tumor treatment while minimizing damage to surrounding healthy tissues. So far, APCC has treated over 1400 patients, the youngest being a 10-month-old boy, and has achieved remarkable clinical outcomes, elevating the quality of life of cancer warriors.
Belgium supports innovations in cancer care
Didier Vanderhasselt, Ambassador of Belgium to India, honored the event as its chief guest, and said, “From the historic beginnings of diplomatic relations between Belgium and India to the present day, where pioneering advancements in healthcare stand testament to our enduring collaboration. Belgium is proud to support initiatives that drive innovation and excellence in cancer care.”
In a powerful statement marking the occasion, Dr. Preetha Reddy, Executive Vice Chairperson of Apollo Hospitals Enterprises Limited, emphasized the transformative impact of their collaboration with IBA. “This alliance is a testament to our dedication to forging global healthcare partnerships. By uniting our strengths and expertise, we significantly enhance our collective capacity to tackle cancer worldwide.
The training program is a landmark event in our partnership, facilitating an unhindered exchange of knowledge across frontiers. It equips oncologists globally with cutting-edge insights into Proton Beam Therapy. This collaboration is a clear manifestation of our unified vision to democratize access to innovative treatments worldwide, heralding a new era in healthcare where advanced solutions are within reach for everyone.”
